CancerWorld/LinkedIn
Mar 7, 2025, 06:43
55% Reduction in Cancer Recurrence? Aspirin Shows Promise – CancerWorld
CancerWorld shared a post on LinkedIn:
“55% Reduction in Cancer Recurrence? Aspirin Shows Promise!
A daily low-dose aspirin for three years reduced colorectal cancer recurrence by 55% in patients with a mutated PI3K gene.
New research suggests that adjuvant low-dose aspirin could be a simple, low-cost strategy to help prevent recurrence in high-risk patients.
Could this widely available pill become a game-changer in cancer care?
More posts featuring CancerWorld.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 8, 2025, 15:53
May 8, 2025, 15:14
May 8, 2025, 15:13
May 8, 2025, 14:27